Clinical trial
Effect of Modified Huanglian Wendan Decoction on Oxidative Stress in Patients With Metabolic Syndrome
NCT07702669 is registered in ClinicalTrials.gov with First Affiliated Hospital of Heilongjiang Chinese Medicine University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Modified Huanglian Wendan Decoction on Oxidative Stress in Patients With Metabolic Syndrome
- Lead sponsor
- First Affiliated Hospital of Heilongjiang Chinese Medicine University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2023
- Completion date
- August 31, 2025
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.